At PromiseCare Medical Group in Hemet, California, a game-changing solution for severe aortic stenosis is available: Transcatheter Aortic Valve Replacement (TAVR).
This minimally invasive procedure, performed by an experienced healthcare team, replaces the faulty valve in under an hour, restoring blood flow and transforming quality of life. Patients can expect to take a deep breath without straining and enjoy everyday activities without exhaustion.
TAVR usually leads to quick symptom relief and a reduced hospital stay. At PromiseCare Medical Group, the healthcare team supports patients throughout their journey, from preparation to recovery, ensuring they understand the benefits, risks, and outcomes of this transformative choice.
By exploring TAVR with the experts at PromiseCare Medical Group, patients can make informed decisions about their care and take the first step towards a healthier, more active life.
Overview
Aortic valve narrowing can become a significant obstacle, restricting blood flow and causing symptoms such as shortness of breath, fatigue, and concern about the future.
Transcatheter Aortic Valve Replacement (TAVR) offers a solution, replacing the narrowed valve with a new one and restoring blood flow.
TAVR is a minimally invasive procedure that eliminates the need for open-heart surgery. The procedure typically involves a small incision in the groin to access the femoral artery. The replacement valve is then guided through the artery and into the heart, where it’s secured.
TAVR offers benefits such as shorter hospital stays, quicker recovery, and almost immediate symptom relief. This procedure marks a significant advancement for high-risk patients, providing a safer alternative to traditional surgery.
TAVR enables patients to reclaim their lives from severe aortic stenosis and enjoy unrestricted freedom. However, it is essential to consult a healthcare team to determine if TAVR is the right choice.
Types
Behind the scenes of this groundbreaking therapy lies a complex landscape of options and innovations. The various types of TAVR procedures each have unique characteristics and benefits. The replacement valve, typically made from animal tissue, is delivered to the heart via a catheter and expanded at the aortic valve site.
What sets these procedures apart is the access route used to reach the heart. Three primary access routes are used: transfemoral, transapical, and transcaval. The transfemoral approach involves inserting the catheter through the femoral artery in the groin, while the transapical method requires a small incision in the chest. The transcaval approach utilizes blood vessels in the stomach area, often reserved for high-risk patients.
New techniques, such as the BASILICA procedure, are being researched to mitigate complications like coronary artery obstruction. TAVR valves with metal frames made from nickel and titanium are available in various sizes to accommodate different patient anatomies. Each type of TAVR procedure is designed to cater to unique patient needs and guarantee a successful outcome.
Why it’s done
TAVR is performed to treat severe aortic stenosis, a condition characterized by the narrowing of the aortic valve, which can lead to debilitating symptoms such as chest pain, shortness of breath, and fatigue.
This procedure is typically recommended for patients who are symptomatic and at high risk for complications from open-heart surgery due to age or other comorbid conditions.
Some key benefits of TAVR include:
- A minimally invasive procedure that reduces the risks associated with open-heart surgery
- Quicker recovery times and shorter hospital stays compared to traditional surgical aortic valve replacement
- An effective treatment option for patients with ineffective biological tissue aortic valves that require replacement
The ultimate goal of TAVR remains the same as medical innovators refine and expand the types of procedures: to bring relief to patients struggling with severe aortic stenosis.
This procedure offers a minimally invasive alternative to traditional open-heart surgery, making it a viable option for those who may not be candidates for more invasive treatments.
Who it’s for
Patients with severe aortic stenosis often experience symptoms such as chest pain and shortness of breath, leading them to seek treatment options. TAVR is indicated for individuals with severe aortic stenosis who are experiencing symptoms, as well as those with ineffective biological tissue valves that require replacement.
TAVR is suitable for patients across all risk levels, including those considered high-risk for traditional open-heart surgery due to other health conditions, such as lung or kidney disease.
A thorough evaluation by a heart team, consisting of cardiologists and surgeons, will determine if TAVR is the right treatment path based on overall health and valve condition. The evaluation will assess symptoms, medical history, and test results to make an informed decision.
If a patient is a candidate, TAVR can offer a minimally invasive solution to replace the faulty valve and improve quality of life.
Risks
What challenges await those contemplating TAVR? Understanding the possible complications is crucial when evaluating the advantages of this transformative procedure. Although TAVR has transformed the management of aortic stenosis, it carries certain risks.
One may face bleeding and blood vessel complications during catheter insertion or valve deployment. Additionally, there’s a risk of stroke, which occurs in a small percentage of patients.
Other potential risks include heart rhythm disturbances, which may require a permanent pacemaker, and kidney disease exacerbation.
Valve-related complications can also occur. These may include paravalvular regurgitation or misplacement.
It’s crucial for medical professionals to carefully consider individual factors and utilize proper procedural techniques to minimize risks.
Close monitoring is also necessary. Complications, when identified promptly, can be managed with timely treatment.
Careful weighing of these risks against the benefits of TAVR will inform a patient’s decision.
Recognizing these risks allows for better navigation of the TAVR process, ensuring patients can make well-informed choices about their care and medical requirements.
How you prepare
Preparation is key to a smooth and successful TAVR procedure. A thorough health evaluation, which includes X-rays, CT scans, blood tests, and an echocardiogram, is necessary.
It’s essential to be honest about medications and allergies, as certain drugs may need to be adjusted or paused before the procedure.
Fasting from midnight before the procedure is also required, so it’s crucial not to eat or drink anything after this time.
Quitting smoking is strongly recommended to reduce potential lung complications during and after surgery.
Specific instructions will be provided on what personal items to bring, such as comfortable clothing and eyeglasses, while jewelry and contact lenses should be avoided during the procedure.
Following these steps ensures preparation for the TAVR procedure.
To ensure a successful outcome, it’s essential to ask questions or express concerns. A thorough understanding of the procedure and necessary preparations can help guarantee a smooth experience.
What you can expect
The TAVR procedure, which is minimally invasive and typically lasts less than an hour, involves replacing the aortic valve. Sedation ensures comfort throughout the process.
- A catheter is usually inserted through the femoral artery in the groin, but alternative access points in the neck or chest may be used if necessary.
After the procedure, the patient is transferred to an intensive care unit (ICU) for monitoring before moving to a regular room.
Many patients are discharged as early as the day after the procedure, with recovery involving a gradual return to daily activities – walking often begins on the same day as the procedure.
During recovery, specific care instructions must be followed, and prescribed medications, including blood thinners, are taken to support healing and prevent potential complications.
Follow-up appointments are necessary to monitor progress, usually at 30 days and one year after the procedure. With proper guidance, a smooth recovery is achievable.
Results
Findings from TAVR indicate substantial enhancements in symptoms related to aortic stenosis, with patients experiencing a notable boost in quality of life post-procedure. Hospital readmissions decrease, and recovery durations are shorter than conventional surgical aortic valve replacement (SAVR).
Long-term results show that survival rates for this procedure are comparable to those of patients who have had open-heart surgery, particularly among high-risk groups. The procedure boasts a success rate exceeding 90%, with most patients demonstrating immediate hemodynamic benefits following valve implantation. These benefits correspond to enhanced valve function that can persist for five years or longer.
Valve function improves immediately, resulting in clear improvements in symptoms and quality of life. Evidence indicates that TAVR is a trustworthy approach to addressing aortic stenosis. It can lead to more effective symptom management and support better long-term health outcomes.